BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36087121)

  • 21. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
    Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
    Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5-ALA dose on resection of glioblastoma.
    Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
    J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of primary motor cortex tumors: feasibility and surgical outcomes.
    Magill ST; Han SJ; Li J; Berger MS
    J Neurosurg; 2018 Oct; 129(4):961-972. PubMed ID: 29219753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
    Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
    J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection.
    Prada F; Bene MD; Fornaro R; Vetrano IG; Martegani A; Aiani L; Sconfienza LM; Mauri G; Solbiati L; Pollo B; DiMeco F
    Neurosurg Focus; 2016 Mar; 40(3):E7. PubMed ID: 26926065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].
    Jacquesson T; Ducray F; Maucort-Boulch D; Armoiry X; Louis-Tisserand G; Mbaye M; Pelissou-Guyotat I; Guyotat J
    Neurochirurgie; 2013 Feb; 59(1):9-16. PubMed ID: 23318102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique?
    Picart T; Armoiry X; Berthiller J; Dumot C; Pelissou-Guyotat I; Signorelli F; Guyotat J
    Neurochirurgie; 2017 Jun; 63(3):189-196. PubMed ID: 28522184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
    Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
    Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
    Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
    Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histology of high-grade glioma samples resected using 5-ALA fluorescent headlight and loupe combination.
    Giantini-Larsen AM; Kharas N; Pisapia D; Schwartz TH
    Acta Neurochir (Wien); 2023 Feb; 165(2):567-575. PubMed ID: 36656388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
    Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
    World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection of the contrast-enhancing tumor in diffuse gliomas bordering eloquent areas using electrophysiology and 5-ALA fluorescence: evaluation of resection rates and neurological outcome-a systematic review and meta-analysis.
    Peters DR; Halimi F; Ozduman K; Levivier M; Conti A; Reyns N; Tuleasca C
    Neurosurg Rev; 2023 Jul; 46(1):185. PubMed ID: 37498398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Interobserver Agreement in the Subjective Classification of 5-Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas.
    Mischkulnig M; Kiesel B; Borkovec M; Wadiura LI; Benner D; Hosmann A; Hervey-Jumper S; Knosp E; Roessler K; Berger MS; Widhalm G
    Lasers Surg Med; 2020 Nov; 52(9):814-821. PubMed ID: 32147864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
    Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
    Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
    Roder C; Stummer W; Coburger J; Scherer M; Haas P; von der Brelie C; Kamp MA; Löhr M; Hamisch CA; Skardelly M; Scholz T; Schipmann S; Rathert J; Brand CM; Pala A; Ernemann U; Stockhammer F; Gerlach R; Kremer P; Goldbrunner R; Ernestus RI; Sabel M; Rohde V; Tabatabai G; Martus P; Bisdas S; Ganslandt O; Unterberg A; Wirtz CR; Tatagiba M
    J Clin Oncol; 2023 Dec; 41(36):5512-5523. PubMed ID: 37335962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Motor Evoked Potential Monitoring and Subcortical Dynamic Mapping in Motor Eloquent Tumors Allows Safer and Extended Resections.
    Moiyadi A; Velayutham P; Shetty P; Seidel K; Janu A; Madhugiri V; Singh VK; Patil A; John R
    World Neurosurg; 2018 Dec; 120():e259-e268. PubMed ID: 30138733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-ALA Enhanced Fluorescence-Guided Microscopic to Endoscopic Resection of Deep Frontal Subcortical Glioblastoma Multiforme.
    Strickland BA; Zada G
    World Neurosurg; 2021 Apr; 148():65. PubMed ID: 33453427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
    Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
    Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.